These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 37108584)
1. Effect of Resveratrol on Markers of Oxidative Stress and Sirtuin 1 in Elderly Adults with Type 2 Diabetes. García-Martínez BI; Ruiz-Ramos M; Pedraza-Chaverri J; Santiago-Osorio E; Mendoza-Núñez VM Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108584 [TBL] [Abstract][Full Text] [Related]
2. The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial. Seyyedebrahimi S; Khodabandehloo H; Nasli Esfahani E; Meshkani R Acta Diabetol; 2018 Apr; 55(4):341-353. PubMed ID: 29357033 [TBL] [Abstract][Full Text] [Related]
3. Impact of sirtuin-1 expression on H3K56 acetylation and oxidative stress: a double-blind randomized controlled trial with resveratrol supplementation. Bo S; Togliatto G; Gambino R; Ponzo V; Lombardo G; Rosato R; Cassader M; Brizzi MF Acta Diabetol; 2018 Apr; 55(4):331-340. PubMed ID: 29330620 [TBL] [Abstract][Full Text] [Related]
4. [Sirtuin 1 as a potential molecular target of resveratrol in selected diseases]. Frankenstein H; Robak J; Lewandowska U; Owczarek K Postepy Biochem; 2024 Jan; 69(4):264-273. PubMed ID: 39012699 [TBL] [Abstract][Full Text] [Related]
5. Role of resveratrol supplementation in regulation of glucose hemostasis, inflammation and oxidative stress in patients with diabetes mellitus type 2: A randomized, placebo-controlled trial. Mahjabeen W; Khan DA; Mirza SA Complement Ther Med; 2022 Jun; 66():102819. PubMed ID: 35240291 [TBL] [Abstract][Full Text] [Related]
6. Oxidative stress, glutathione status, sirtuin and cellular stress response in type 2 diabetes. Calabrese V; Cornelius C; Leso V; Trovato-Salinaro A; Ventimiglia B; Cavallaro M; Scuto M; Rizza S; Zanoli L; Neri S; Castellino P Biochim Biophys Acta; 2012 May; 1822(5):729-36. PubMed ID: 22186191 [TBL] [Abstract][Full Text] [Related]
7. The effects of resveratrol on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease. Hoseini A; Namazi G; Farrokhian A; Reiner Ž; Aghadavod E; Bahmani F; Asemi Z Food Funct; 2019 Sep; 10(9):6042-6051. PubMed ID: 31486447 [TBL] [Abstract][Full Text] [Related]
9. Impact of resveratrol supplementation on inflammatory, antioxidant, and periodontal markers in type 2 diabetic patients with chronic periodontitis. Javid AZ; Hormoznejad R; Yousefimanesh HA; Haghighi-Zadeh MH; Zakerkish M Diabetes Metab Syndr; 2019; 13(4):2769-2774. PubMed ID: 31405706 [TBL] [Abstract][Full Text] [Related]
10. Activation of FoxO1/SIRT1/RANKL/OPG pathway may underlie the therapeutic effects of resveratrol on aging-dependent male osteoporosis. Ameen O; Yassien RI; Naguib YM BMC Musculoskelet Disord; 2020 Jun; 21(1):375. PubMed ID: 32532246 [TBL] [Abstract][Full Text] [Related]
11. Resveratrol Pretreatment Ameliorates Concanavalin A-Induced Advanced Renal Glomerulosclerosis in Aged Mice through Upregulation of Sirtuin 1-Mediated Klotho Expression. Chen CC; Chang ZY; Tsai FJ; Chen SY Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32942691 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Resveratrol in Type 1 Diabetes Patients: A Two-Month Preliminary Exploratory Trial. Movahed A; Raj P; Nabipour I; Mahmoodi M; Ostovar A; Kalantarhormozi M; Netticadan T Nutrients; 2020 Jan; 12(1):. PubMed ID: 31935938 [TBL] [Abstract][Full Text] [Related]
14. Effects of 6 months of resveratrol versus placebo on pentraxin 3 in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial. Bo S; Ponzo V; Evangelista A; Ciccone G; Goitre I; Saba F; Procopio M; Cassader M; Gambino R Acta Diabetol; 2017 May; 54(5):499-507. PubMed ID: 28238190 [TBL] [Abstract][Full Text] [Related]
15. Resveratrol promotes osteogenesis via activating SIRT1/FoxO1 pathway in osteoporosis mice. Jiang Y; Luo W; Wang B; Wang X; Gong P; Xiong Y Life Sci; 2020 Apr; 246():117422. PubMed ID: 32057903 [TBL] [Abstract][Full Text] [Related]
16. Resveratrol ameliorates inflammatory and oxidative stress in type 2 diabetic Goto-Kakizaki rats. Szkudelska K; Okulicz M; Hertig I; Szkudelski T Biomed Pharmacother; 2020 May; 125():110026. PubMed ID: 32092822 [TBL] [Abstract][Full Text] [Related]
17. The mitochondrial antioxidant SS-31 increases SIRT1 levels and ameliorates inflammation, oxidative stress and leukocyte-endothelium interactions in type 2 diabetes. Escribano-Lopez I; Diaz-Morales N; Iannantuoni F; Lopez-Domenech S; de Marañon AM; Abad-Jimenez Z; Bañuls C; Rovira-Llopis S; Herance JR; Rocha M; Victor VM Sci Rep; 2018 Oct; 8(1):15862. PubMed ID: 30367115 [TBL] [Abstract][Full Text] [Related]
18. Resveratrol protects human endothelium from H(2)O(2)-induced oxidative stress and senescence via SirT1 activation. Kao CL; Chen LK; Chang YL; Yung MC; Hsu CC; Chen YC; Lo WL; Chen SJ; Ku HH; Hwang SJ J Atheroscler Thromb; 2010 Sep; 17(9):970-9. PubMed ID: 20644332 [TBL] [Abstract][Full Text] [Related]
19. Aging: Change in SIRT1 and Enzymatic Profile Promotes a Decrease in the Antioxidant Capacity of Resveratrol in Human Leukocytes Franco FN; de Cassia Cardoso L; Moura Silva BN; Rodrigues de Araújo G; Chaves MM Curr Aging Sci; 2023; 16(1):56-64. PubMed ID: 35546771 [TBL] [Abstract][Full Text] [Related]
20. Resveratrol Promotes Recovery of Hearing following Intense Noise Exposure by Enhancing Cochlear SIRT1 Activity. Xiong H; Ou Y; Xu Y; Huang Q; Pang J; Lai L; Zheng Y Audiol Neurootol; 2017; 22(4-5):303-310. PubMed ID: 29393101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]